Suficiência de Vitamina D: risco reduzido para morbidade e mortalidade na Covid-19 * Vitamin D Sufficiency Reduced Risk for Morbidity and Mortality in COVID-19 Patients – Preprints with The Lancet

Tradução livre para o português do Administrador deste Site, ao final acesso à publicação completa original.




A redução significativa da CRP sérica, um marcador inflamatório, juntamente com o aumento da porcentagem de linfócitos sugerem que a suficiência de vitamina D também pode ajudar a modular a resposta imune, possivelmente reduzindo o risco de tempestade de citocinas em resposta a esta infecção viral. Portanto, recomenda-se que a melhoria do status da vitamina D na população em geral e em pacientes hospitalizados em particular tenha um benefício potencial na redução da gravidade das morbidades e mortalidade associadas à aquisição do COVID-19



Fonte: Suficiência de vitamina D reduziu risco de morbimortalidade em pacientes COVID-19

por Zhila Maghbooli, Mehdi Ebrahimi, Arash Shirvani, Mehrad Nasiri, Marzieh Pazoki, Samira Kafan, Hedieh Moradi Tabriz, Azar Hadadi, Mahnaz Montazeri, Mohammad Ali Sahraian e Michaelmad Ali Sahraian Holick :: SSRN

Image 20200803

1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. New
England Journal of Medicine 2020.
2. Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta bio-medica : Atenei Parmensis 2020;
91(1): 157-60.
3. Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and
middle-aged patients. Journal of Infection 2020.
4. Organization WH. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, 28 January 2020: World Health Organization, 2020.
5. Lamers MM, Beumer J, van der Vaart J, et al. SARS-CoV-2 productively infects human gut enterocytes.
Science 2020: eabc1669.
6. Ortega JT, Serrano ML, Pujol FH, Rangel HR. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis. EXCLI journal 2020; 19: 410.
7. Gheblawi M, Wang K, Viveiros A, et al. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circulation research 2020; 126(10): 1456-74.
8. Gruber-Bzura BM. Vitamin D and Influenza-Prevention or Therapy? International journal of molecular
sciences 2018; 19(8).
9. Xu J, Yang J, Chen J, Luo Q, Zhang Q, Zhang H. Vitamin D alleviates lipopolysaccharideinduced acute lung injury via regulation of the reninangiotensin system. Molecular medicine reports 2017; 16(5): 7432-8.
10. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet respiratory medicine 2020; 8(4): 420-2.
11. Larijani B, Hossein-Nezhad A, Feizabad E, et al. Vitamin D deficiency, bone turnover markers and causative factors among adolescents: a cross-sectional study. Journal of Diabetes & Metabolic Disorders 2016; 15(1): 46.
12. Tabrizi R, Moosazadeh M, Akbari M, et al. High prevalence of vitamin d deficiency among iranian population: A systematic review and meta-analysis. Iranian journal of medical sciences 2018; 43(2): 125.
13. Talebpour M, Hadadi A, Oraii A, Ashraf H. Rationale and Design of a Registry in a Referral and Educational
Medical Center in Tehran, Iran: Sina Hospital Covid-19 Registry (SHCo-19R).
14. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism 2011; 96(7): 1911-30.
15. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. The Journal of Clinical Endocrinology & Metabolism 2011; 96(1): 53-8.
16. Bordelon P, Ghetu MV, Langan RC. Recognition and management of vitamin D deficiency. American family physician 2009; 80(8): 841-6.
17. Dawson-Hughes B, Mithal A, Bonjour JP, et al. IOF position statement: vitamin D recommendations for older adults. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2010; 21(7): 1151-4.
18. Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clinic proceedings; 2013: Elsevier; 2013. p. 720-55.
19. Shirvani A, Kalajian TA, Song A, Holick MF. Disassociation of Vitamin D’s calcemic Activity and noncalcemic Genomic Activity and individual Responsiveness: A Randomized controlled Double-Blind clinical trial. Scientific reports 2019; 9(1): 1-12.
20. Niculescu DA, Deacu LG, Caragheorgheopol A, et al. Seasonal periodicity of serum parathyroid hormone
and its relation with vitamin D in Romania. Archives of Osteoporosis 2020; 15: 1-8.
21. Hope-Simpson RE. The role of season in the epidemiology of influenza. The Journal of hygiene 1981; 86(1): 35-47.
22. Kroll MH, Bi C, Garber CC, et al. Temporal relationship between vitamin D status and parathyroid hormone in the United States. PloS one 2015; 10(3).
23. Berry DJ, Hesketh K, Power C, Hypponen E. Vitamin D status has a linear association with seasonal infections and lung function in British adults. The British journal of nutrition 2011; 106(9): 1433-40.
This preprint research paper has not been peer reviewed. Electronic copy available at:
24. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 2017; 356: i6583-i.
25. Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2011; 50(3): 194-200.
26. Shiozawa K, Shiozawa S, Shimizu S, Fujita T. 1 alpha,25-dihydroxyvitamin D3 inhibits pokeweed mitogenstimulated human B-cell activation: an analysis using serum-free culture conditions. Immunology 1985; 56(1): 161-7.
27. Bruce D, Ooi JH, Yu S, Cantorna MT. Vitamin D and host resistance to infection? Putting the cart in front of the horse. Experimental biology and medicine (Maywood, NJ) 2010; 235(8): 921-7.
28. Bikle DD. Extraskeletal actions of vitamin D. Annals of the New York Academy of Sciences 2016; 1376(1): 29-52.
29. Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal transduction and targeted therapy 2020; 5(1):13.
30. Daneshkhah A, Agrawal V, Eshein A, Subramanian H, Roy HK, Backman V. The Possible Role of Vitamin D in Suppressing Cytokine Storm and Associated Mortality in COVID-19 Patients. medRxiv 2020.
31. Ling W. C-reactive protein levels in the early stage of COVID-19. Medecine et maladies infectieuses 2020.
32. Tan C, Huang Y, Shi F, et al. C‐reactive protein correlates with CT findings and predicts severe COVID‐19 early. Journal of Medical Virology 2020.
33. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly Rep 2020;69:382–386.
34. Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clinical and Experimental Research 2020: 1.